A common polymorphism in the cystatin C gene is associated with increased r
isk of developing Alzheimer's disease (AD). To explore possible neuropathol
ogical consequences of this genetic association, we examined expression of
cystatin C in brains from 22 AD and 11 control patients by immunohistochemi
stry. In the temporal cortex of aft AD brains, there was strong cystatin C
immunostaining of neurons and activated glia, whereas staining was absent o
r minimal in 7 of the 11 control brains. Neuronal staining of cystatin C in
AD brains was primarily limited to pyramidal neurons in cortical layers II
I and V, which are the neurons most susceptible to cell death in AD. The in
crease in cystatin C staining in AD was independent of cystatin C genotype.
Immunostaining of cystatin C within neurons showed a punctate distribution
, which co-localized with the endosomal/lysosomal proteinase, cathepsin B.
A primarily glial source for cystatin C was suggested by parallel studies u
sing in situ hybridization of mouse brain. In human AD brain, there was lit
tle co-localization of cystatin C with parenchymal A beta deposits, althoug
h a small fraction of cerebral blood vessels and neurofibrillary tangles we
re cystatin C-positive. The regional distribution of cystatin C neuronal im
munostaining also duplicated the pattern of neuronal susceptibility in AD b
rains: the strongest staining was found in the entorhinal cortex, in the hi
ppocampus, and in the temporal cortex; fewer pyramidal neurons were stained
in frontal, parietal, and occipital lobes. These neuropathological observa
tions reinforce the association between cystatin C and AD, and support a mo
del of cystatin C involvement in the process of neuronal death in AD.